Analyst Reco. Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
3.85 ^USD	-1.53%		-10.47%	-21.11%

Apr. 05	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	CI
Mar. 06	JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	Mar. 06	MT
UBS Adjusts Akoya Biosciences Price Target to $7.50 From $7, Maintains Buy Rating	Mar. 05	MT
Stephens Adjusts Price Target on Akoya Biosciences to $9 From $14, Maintains Overweight Rating	Nov. 13	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $8 From $15, Keeps Overweight Rating	23-10-24	MT
UBS Cuts Akoya Biosciences Price Target to $7 From $12, Maintains Buy Rating	23-10-12	MT
UBS Adjusts Akoya Biosciences Price Target to $12 From $13, Maintains Buy Rating	23-08-08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $15 From $16, Maintains Overweight Rating	23-08-08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $16 From $17, Maintains Overweight Rating	23-05-10	MT
UBS Adjusts Akoya Biosciences Price Target to $13 From $14, Maintains Buy Rating	23-05-09	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $17 From $18, Maintains Overweight Rating	23-03-08	MT
UBS Initiates Coverage on Akoya Biosciences With Buy Rating, $14 Price Target	23-02-02	MT
Capital One Initiates Akoya Biosciences at Overweight Rating With $19 Price Target	22-11-03	MT
Stephens Starts Akoya Biosciences at Overweight With $16 Price Target	22-10-06	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $17 From $14, Reiterates Overweight Rating	22-08-18	MT
BTIG Starts Akoya Biosciences at Buy With $16 Price Target	22-06-22	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $14 From $18, Reiterates Overweight Rating	22-05-16	MT
Morgan Stanley Trims Akoya Biosciences Price Target to $18 From $19, Maintains Overweight Rating	22-05-09	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $18 From $23, Reiterates Overweight Rating	22-03-17	MT
JPMorgan Adjusts Akoya Biosciences' Price Target to $20 from $25, Keeps Overweight Rating	22-03-15	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $19 from $20, Keeps Overweight Rating	22-03-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Analyst Reco.

Filters